Suppr超能文献

一千个肿瘤中的转录肿瘤内异质性特征。

Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.

机构信息

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

出版信息

Nature. 2023 Jun;618(7965):598-606. doi: 10.1038/s41586-023-06130-4. Epub 2023 May 31.

Abstract

Each tumour contains diverse cellular states that underlie intratumour heterogeneity (ITH), a central challenge of cancer therapeutics. Dozens of recent studies have begun to describe ITH by single-cell RNA sequencing, but each study typically profiled only a small number of tumours and provided a narrow view of transcriptional ITH. Here we curate, annotate and integrate the data from 77 different studies to reveal the patterns of transcriptional ITH across 1,163 tumour samples covering 24 tumour types. Among the malignant cells, we identify 41 consensus meta-programs, each consisting of dozens of genes that are coordinately upregulated in subpopulations of cells within many tumours. The meta-programs cover diverse cellular processes including both generic (for example, cell cycle and stress) and lineage-specific patterns that we map into 11 hallmarks of transcriptional ITH. Most meta-programs of carcinoma cells are similar to those identified in non-malignant epithelial cells, suggesting that a large fraction of malignant ITH programs are variable even before oncogenesis, reflecting the biology of their cell of origin. We further extended the meta-program analysis to six common non-malignant cell types and utilize these to map cell-cell interactions within the tumour microenvironment. In summary, we have assembled a comprehensive pan-cancer single-cell RNA-sequencing dataset, which is available through the Curated Cancer Cell Atlas website, and leveraged this dataset to carry out a systematic characterization of transcriptional ITH.

摘要

每个肿瘤都包含多种细胞状态,这些状态是肿瘤异质性(ITH)的基础,这是癌症治疗的一个主要挑战。最近数十项研究已经开始通过单细胞 RNA 测序来描述 ITH,但每项研究通常只对少数肿瘤进行了分析,并且对转录组 ITH 的观察角度较窄。在这里,我们整理、注释并整合了来自 77 项不同研究的数据,以揭示 1163 个肿瘤样本中 24 种肿瘤类型的转录组 ITH 模式。在恶性细胞中,我们鉴定出 41 个共识元程序,每个元程序由数十个基因组成,这些基因在许多肿瘤的细胞亚群中协同上调。这些元程序涵盖了多种细胞过程,包括通用(例如,细胞周期和应激)和谱系特异性模式,我们将这些模式映射到转录组 ITH 的 11 个特征中。大多数癌细胞的元程序与在非恶性上皮细胞中鉴定的元程序相似,这表明即使在癌变之前,恶性 ITH 程序的很大一部分也是可变的,反映了其起源细胞的生物学特性。我们进一步将元程序分析扩展到六种常见的非恶性细胞类型,并利用这些类型来映射肿瘤微环境中的细胞间相互作用。总之,我们已经组装了一个全面的泛癌单细胞 RNA-seq 数据集,可通过精心策划的癌症细胞图谱网站获得,并利用该数据集对转录组 ITH 进行了系统的特征描述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验